You are here: Home » PTI Stories » National » News
Business Standard

New drug to prevent, treat alcoholism in the offing

Topics
Health Medical Pharma

Press Trust of India  |  Washington 

Scientists say they have identified a gene that could help develop new drugs to prevent and treat alcoholism and mood disorders in people.

The researchers at the Oregon Health & Science University(OHSU) in the US discovered the gene that had lower expression in the brains of nonhuman primates that voluntarily consumed heavy amounts of alcohol compared with those that drank less.

The study, published in the journal Neuropsychopharmacology, unravelled a link between alcohol and how it modulates the levels of activity of this particular gene.

Researchers discovered that when they increased the levels of the gene encoded protein in mice, they reduced alcohol consumption by almost 50 per cent without affecting the total amount of fluid consumed or their overall well-being.

They modified the levels of the protein encoded by a single gene -- GPR39 -- which is a zinc-binding receptor previously associated with depression.

The prevalence rates of co-occurring mood and alcohol use disorders are high, with individuals with alcohol use disorder being 3.7 times more likely to have major depression than those who do not abuse alcohol.

Using a commercially available substance that mimics the activity of the GPR39 protein, the researchers found that targeting this gene dramatically reduced alcohol consumption in mice.

"The study highlights the importance of using cross-species approaches to identify and test relevant drugs for the treatment of alcohol use disorder," said Rita Cervera-Juanes, a research assistant professor at OHSU.

To determine whether the same mechanism affects people, the researchers are now examining postmortem tissue samples from the brains of people who suffered from alcoholism.

Currently, there are only a handful of treatments for alcoholism approved by the US Food and Drug Administration, researchers said.

By testing the effect of the substance in reducing ethanol consumption in mice -- in addition to its previously reported link in reducing depression-like symptoms -- the findings may point the way towards developing a drug that both prevents and treats chronic alcoholism and mood disorders in people.

"We are finding novel targets for which there are drugs already available, and they can be repurposed to treat other ailments," Cervera-Juanes said.

"For alcoholism, this is huge because there are currently only a handful of FDA-approved drugs," she said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, February 11 2019. 12:50 IST
RECOMMENDED FOR YOU